1 Clinical Trials associated with NGN-401 NCT05898620 / RecruitingPhase 1/2 A Phase 1/2, Open-Label Clinical Study to Evaluate Safety, Tolerability, and Efficacy of NGN-401 in Pediatric Subjects with Rett Syndrome This study will evaluate the safety profile of the investigational gene therapy, ...